On April 28, 2026, Danish dental technology company 3Shape announced that its Dx Software platform received FDA 510(k) clearance for commercial use in U.S. dental clinics. The AI-powered diagnostic tool is designed to assist dentists in detecting surface and proximal caries, plaque accumulation, tooth wear, and gingival recession — all from intraoral scan data and clinical images.
The clearance represents a significant milestone in the growing wave of AI diagnostic tools entering clinical dentistry. For Canadian dental professionals, particularly those practising in Ontario and the Greater Toronto Area, this development raises important questions about when — and how — similar tools will become available under Health Canada's regulatory framework.
What 3Shape Dx Software Actually Does
Unlike traditional imaging software that simply displays radiographs for manual interpretation, 3Shape's Dx platform uses machine learning algorithms to flag potential pathology in real time. The software analyses intraoral images and scan data to identify:
- Surface and interproximal caries that may be missed during visual examination
- Plaque distribution patterns across the dentition
- Early-stage tooth wear and erosion
- Gingival recession and soft tissue changes over time
The system is designed to function as a clinical decision support tool — meaning it highlights areas of concern for the dentist to evaluate, rather than making autonomous diagnostic decisions. This distinction matters from a regulatory perspective, as it positions the software as an aid rather than a replacement for clinical judgment.
The Broader AI Diagnostics Landscape in Dentistry
3Shape joins a growing cohort of dental AI companies that have secured regulatory clearance in recent months. Pearl, Overjet, and VideaHealth have all received FDA clearance for various AI diagnostic applications, from caries detection to periodontal bone loss assessment. The global dental AI market is projected to exceed $1.5 billion CAD by 2028, driven by the push for earlier detection and more consistent diagnostic outcomes.
Pro Tip: If your practice uses a 3Shape TRIOS scanner, watch for integration announcements. AI diagnostic overlays that work directly within your existing scanning workflow eliminate the need for separate software platforms and reduce friction during patient appointments.
What This Means for Canadian Dentists
FDA clearance does not automatically translate to availability in Canada. Health Canada operates an independent medical device approval process under the Medical Devices Regulations. AI-based diagnostic software is classified as a Class II or Class III medical device, depending on the level of clinical decision-making involved.
As of May 2026, no AI dental diagnostic software has received a full Health Canada medical device licence for autonomous caries detection, though several manufacturers have applications under review. Canadian dentists should expect a 12- to 24-month lag between FDA clearance and Health Canada approval for most AI diagnostic tools.
The Royal College of Dental Surgeons of Ontario (RCDSO) has not yet issued specific practice guidelines on AI-assisted diagnostics, but its existing standards on diagnostic imaging and record-keeping apply. Any AI tool used in an Ontario dental practice must comply with the Personal Health Information Protection Act (PHIPA) and the Personal Information Protection and Electronic Documents Act (PIPEDA) with respect to patient data handling.
Privacy and Data Considerations
AI diagnostic tools typically require cloud-based processing, which introduces questions about where patient data is stored and processed. Canadian dental practices must ensure that any AI platform they adopt stores patient data on Canadian servers or, at minimum, in jurisdictions with equivalent privacy protections. This is a requirement under PIPEDA and is particularly relevant for practices in Ontario where PHIPA adds an additional layer of provincial privacy regulation.
Pro Tip: Before evaluating any AI diagnostic platform, request a written data processing agreement from the vendor that specifies server locations, encryption standards, and data retention policies. Your RCDSO obligations around record-keeping do not disappear because a third-party platform is handling the data.
The Clinical Case for AI Diagnostics
The clinical argument for AI-assisted diagnostics is compelling. Studies published in peer-reviewed journals throughout 2025 and early 2026 consistently demonstrate that AI systems detect interproximal caries at rates 10% to 20% higher than unaided clinical examination. For practices in Toronto and the GTA handling high patient volumes, the potential to catch early-stage pathology that might otherwise be missed during a busy schedule represents a meaningful improvement in patient outcomes.
AI diagnostic tools also offer consistency. Unlike human interpretation, which can vary based on fatigue, experience level, and viewing conditions, AI systems apply the same detection parameters to every image. For group practices and dental support organizations operating across multiple locations in the GTA, this consistency can help standardize diagnostic quality across providers.
Cost and ROI Considerations
Early-adopter pricing for AI diagnostic platforms in the U.S. market ranges from $300 to $800 USD per month, depending on features and patient volume. Canadian practices should anticipate similar pricing in CAD once Health Canada-approved options become available, plus potential integration costs with existing practice management software.
The ROI calculation centres on two factors: increased case acceptance from earlier detection (patients are more likely to accept treatment when presented with AI-highlighted pathology on their own images) and reduced liability exposure from missed diagnoses. Practices that currently rely on visual examination alone may find that AI diagnostics pay for themselves through incremental treatment acceptance within the first six to twelve months.
What to Do Now
Canadian dental professionals do not need to rush into AI diagnostics, but staying informed is essential. Here are practical steps for practice owners in Ontario and the GTA:
- Monitor Health Canada's Medical Devices Active Licence Listing for dental AI submissions
- Ensure your intraoral imaging hardware is compatible with emerging AI platforms — most require recent-generation sensors and scanners
- Review your practice's data privacy policies to confirm readiness for cloud-based diagnostic tools
- Attend the Ontario Dental Association (ODA) Annual Spring Meeting 2026 (May 7–9, Metro Toronto Convention Centre) for hands-on demonstrations of AI diagnostic platforms
Pro Tip: The ODA Annual Spring Meeting 2026 features more than 100 continuing education sessions, including dedicated tracks on digital dentistry and AI integration. Use the event to evaluate vendors in person before committing to a platform.
Frequently Asked Questions
Q: Can Canadian dentists legally use AI diagnostic software in their practice right now?
AI software used for clinical diagnostics must hold a valid Health Canada medical device licence. As of May 2026, most dental AI platforms are either awaiting approval or available only as non-diagnostic workflow tools. Using an unlicensed AI tool for diagnostic purposes could expose your practice to regulatory and liability risk under RCDSO standards.
Q: How does AI caries detection compare to traditional bitewing radiographs?
AI-assisted caries detection does not replace radiographic imaging. It analyses existing radiographs and clinical images to flag areas the dentist might investigate further. Studies show AI systems can improve interproximal caries detection rates by 10% to 20% when used alongside standard bitewing radiographs.
Q: What should Ontario dentists ask vendors about data privacy before adopting AI tools?
Ask where patient data is stored and processed, whether servers are located in Canada, what encryption standards are used in transit and at rest, and how data retention and deletion are handled. Confirm compliance with PIPEDA and PHIPA in writing before signing any agreement.
EBIKO Dental will continue monitoring AI diagnostic developments as they relate to the Canadian dental market. For the latest dental industry news and practice insights, visit ebiko.ca.